Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

168 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Home and workforce reintegration one year after thrombectomy in acute stroke patients.
Bode FJ, Zadon NA, Asperger H, Beckonert NM, Ebrahimi T, Nitsch L, Nordsiek J, Meissner JN, Shirvani O, Stösser S, Thielscher C, Dorn F, Lehnen NC, Petzold GC, Weller JM. Bode FJ, et al. Among authors: nitsch l. Eur Stroke J. 2024 Oct 3:23969873241282875. doi: 10.1177/23969873241282875. Online ahead of print. Eur Stroke J. 2024. PMID: 39359171 Free PMC article.
Quantitative assessment of residual tumor is a strong and independent predictor of survival in methylated glioblastoma following radiochemotherapy with CCNU/TMZ.
Zeyen T, Böhm L, Paech D, Schäfer N, Tzaridis T, Duffy C, Nitsch L, Schneider M, Potthoff AL, Schneider-Rothhaar JL, Steinbach JP, Hau P, Kowalski T, Seidel C, Krex D, Grauer O, Goldbrunner R, Zeiner PS, Tabatabai G, Galldiks N, Stummer W, Hattingen E, Glas M, Gkika E, Vatter H, Radbruch A, Herrlinger U, Weller J, Schaub C. Zeyen T, et al. Among authors: nitsch l. Neuro Oncol. 2024 Oct 1:noae205. doi: 10.1093/neuonc/noae205. Online ahead of print. Neuro Oncol. 2024. PMID: 39351820
Machine learning models for outcome prediction in thrombectomy for large anterior vessel occlusion.
Shirvani O, Warnat-Herresthal S, Savchuk I, Bode FJ, Nitsch L, Stösser S, Ebrahimi T, von Danwitz N, Asperger H, Layer J, Meissner J, Thielscher C, Dorn F, Lehnen N, Schultze JL, Petzold GC, Weller JM; GSR‐ET Investigators. Shirvani O, et al. Among authors: nitsch l. Ann Clin Transl Neurol. 2024 Oct;11(10):2696-2706. doi: 10.1002/acn3.52185. Epub 2024 Aug 23. Ann Clin Transl Neurol. 2024. PMID: 39180278 Free PMC article.
Endovascular treatment of primary M3 occlusion stroke in clinical practice: analysis of the German Stroke Registry.
Beckonert NM, Weller JM, Alegiani AC, Boeckh-Behrens T, Deb-Chatterji M, Hamann GF, Krause LU, Lehnen NC, Nitsch L, Poli S, Riedel C, Tiedt S, Zweynert S, Petzold GC, Dorn F, Bode FJ; GSR-ET investigators. Beckonert NM, et al. Among authors: nitsch l. Neurol Res Pract. 2024 Jul 18;6(1):36. doi: 10.1186/s42466-024-00330-7. Neurol Res Pract. 2024. PMID: 39020409 Free PMC article.
Synchronous versus metachronous spinal metastasis: a comparative study of survival outcomes following neurosurgical treatment.
Banat M, Potthoff AL, Hamed M, Borger V, Scorzin JE, Lampmann T, Asoglu H, Khalafov L, Schmeel FC, Paech D, Radbruch A, Nitsch L, Weller J, Herrlinger U, Toma M, Gielen GH, Vatter H, Schneider M. Banat M, et al. Among authors: nitsch l. J Cancer Res Clin Oncol. 2024 Mar 19;150(3):136. doi: 10.1007/s00432-024-05657-x. J Cancer Res Clin Oncol. 2024. PMID: 38502313 Free PMC article.
Correction to: Undetected pseudoprogressions in the CeTeG/NOA-09 trial: hints from postprogression survival and MRI analyses.
Zeyen T, Paech D, Weller J, Schäfer N, Tzaridis T, Duffy C, Nitsch L, Schneider M, Potthoff AL, Steinbach JP, Hau P, Schlegel U, Seidel C, Krex D, Grauer O, Goldbrunner R, Zeiner PS, Tabatabai G, Galldiks N, Stummer W, Hattingen E, Glas M, Radbruch A, Herrlinger U, Schaub C. Zeyen T, et al. Among authors: nitsch l. J Neurooncol. 2023 Nov;165(2):387. doi: 10.1007/s11060-023-04488-z. J Neurooncol. 2023. PMID: 37921974 Free PMC article. No abstract available.
Undetected pseudoprogressions in the CeTeG/NOA-09 trial: hints from postprogression survival and MRI analyses.
Zeyen T, Paech D, Weller J, Schäfer N, Tzaridis T, Duffy C, Nitsch L, Schneider M, Potthoff AL, Steinbach JP, Hau P, Schlegel U, Seidel C, Krex D, Grauer O, Goldbrunner R, Zeiner PS, Tabatabai G, Galldiks N, Stummer W, Hattingen E, Glas M, Radbruch A, Herrlinger U, Schaub C. Zeyen T, et al. Among authors: nitsch l. J Neurooncol. 2023 Sep;164(3):607-616. doi: 10.1007/s11060-023-04444-x. Epub 2023 Sep 20. J Neurooncol. 2023. PMID: 37728779 Free PMC article.
168 results